Nicotine and toxicant exposure among U.S. smokeless tobacco users: Results from 1999 to 2012 national health and nutrition examination survey data

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 12, 2015, Pages 1829-1837

  Rostron, Brian L ^a   Chang, Cindy M ^a   Van Bemmel, Dana M ^a   Xia, Yang ^b   Blount, Benjamin C ^b  

^a CENTER FOR TOBACCO PRODUCTS   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; ARSENIC; BIOLOGICAL MARKER; CADMIUM; COTININE; CREATININE; CYSTEINE DERIVATIVE; LEAD; MERCURY; N ACETYL 2 (2 CYANOETHYL)CYSTEINE; NICOTINE; NITROSAMINE; TOXIC GAS; UNCLASSIFIED DRUG;

ADULT; CARCINOGENICITY; DATA ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH SURVEY; HUMAN; LEAD BLOOD LEVEL; MALE; PRIORITY JOURNAL; REVIEW; SMOKELESS TOBACCO; TOBACCO USE; UNITED STATES; ADVERSE EFFECTS; EPIDEMIOLOGY; MIDDLE AGED; NUTRITION; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NUTRITION SURVEYS; SURVEYS AND QUESTIONNAIRES; TOBACCO, SMOKELESS; UNITED STATES;

EID: 84948734752     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0376     Document Type: Review

References (34)

1. Agaku IT, Vardavas CI, Ayo-Yusuf OA, Alpert HR, Connolly GN. Temporal trends in smokeless tobacco use among US middle and high school students, 2000-2011. JAMA 2013;309:1992-4.
2. Agaku IT, Ayo-Yusuf OA, Vardavas CI, Alpert HR, Connolly GN. Use of conventional and novel smokeless tobacco products among US adolescents. Pediatrics 2013;132:e578-86.
3. Centers for Disease Control and Prevention. Tobacco product use among adults - United States, 2012-2013. Morb Mortal Wkly Rev 2014;63:542-7.
4. Centers for Disease Control and Prevention. Tobacco use among middle and high school students - United States, 2013. Morb Mortal Wkly Rep 2014;63:1021-6.
5. Kann L, Kinchen S, Shanklin SL, Flint KH, Kawkins J, Harris WA, et al. Youth risk behavior surveillance-United States, 2013. MMWR Surveill Summ 2014;63 Suppl 4:1-168.
6. Richter PA, Bishop EE, Wang J, Kaufmann R. Trends in tobacco smoke exposure and blood lead levels among youths and adults in the United States: the National Health and Nutrition Examination Survey, 1999-2008. Prev Chronic Dis 2013;10:E213.
7. Richter PA, Bishop EE, Wang J, Swahn MH. Tobacco smoke exposure and levels of urinary metals in the U.S. youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Int J Environ Res Public Health 2009;6:1930-46.
8. Roethig HJ, Munjal S, Feng S, LiangQ, Sarkar M, Walk RA, et al. Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine Tob Res 2009;11:1216-25.
9. Chen J, Ketterman A, Rostron B, Day H. Biomarkers of exposure among US cigar smokers: an analysis of 1999-2012 National Health and Nutrition Examinatin Survey (NHANES) data. Cancer Epidemiol Biomarkers Prev 2014;23:2906-15.
10. Fisher MT, Bennett CB, Hayes A, Kargalioglu Y, Knox BL, XuD, et al. Sources of and technical approaches for the abatement of tobacco specific nitrosamine formation in moist smokeless tobacco products. Food Chem Toxicol 2012;50:942-8.
11. Hatsukami DK, Lemmonds C, Zhang Y, Murphy SE, Le C, Carmella SG, et al. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. J Natl Cancer Inst 2004;96:844-52.
12. Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res 2008;10:1773-82.
13. Richter P, Hodge K, Stanfill S, Zhang L, Watson C. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobaccospecific nitrosamines. Nicotine Tob Res 2008;10:1645-52.
14. Lawler TS, Stanfill SB, Zhang L, Ashley DL, Watson CH. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines. Food Chem Toxicol 2013;57:380-6.
15. Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, et al. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev 2007; 16:1567-72.
16. Hecht SS, Carmella SG, Edmonds A, Murphy SE, Stepanov I, Luo X, et al. Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco. Tob Control 2008;17:128-31.
17. Naufal ZS, Marano KM, Kathman SJ, Wilson CL. Differential exposure biomarker levels among cigarette smokers and smokeless tobacco consumers in the National Health and Nutrition Examination Survey 1999-2008. Biomarkers 2011;16:222-35.
18. National Center for Health Statistics. National Health and Nutrition Examination Survey; 2012 [cited 2014 Sep 9]. Available from: http://www.cdc.gov/nchs/nhanes.htm.
19. Jarup L, Akesson A. Current status of cadmiumas an environmental health problem. Toxicol Appl Pharmacol 2009;238:201-8.
20. Caraballo RS, Holiday DB, Stellman SD, Mowery PD, Giovino GA, Muscat JE, et al. Comparison of serum cotinine concentration within and across smokers of menthol and nonmenthol cigarette brands among non-Hispanic black and non-Hispanic white U.S. adult smokers, 2001-2006. Cancer Epidemiol Biomarkers Prev 2011;20:1329-40.
21. Jarvis MJ, Russell MA, Benowitz NL, Feyerabend C. Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health 1988;78: 696-8.
22. Xia Y, Bernert JT, Jain RB, Ashley DL, Pirkle JL. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008. Biomarkers 2011;16:112-9.
23. Hecht SS, Yuan JM, Hatsukami D. Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem Res Toxicol 2010;23:1001-8.
24. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002;23:907-22.
25. Agency for Toxic Substances and Disease Registry. ToxFAQs for Cadmium; 2012 [cited 2014 Feb 16]. Available from: http://www.atsdr.cdc.gov/toxfaqs/tf.asp?id=47&tid=15.
26. Agency for Toxic Substances and Disease Registry. ToxFAQs for Lead; 2012 [cited 2014 Feb 16]. Available from: http://www.atsdr.cdc.gov/toxfaqs/tf. asp?id=93&tid=22.
27. Agency for Toxic Substances and Disease Registry. ToxFAQs for Mercury; 1999 [cited 2014 Sep 10]. Available from: http://www.atsdr.cdc.gov/toxfaqs/tf.asp?id=93&tid=22.
28. Agency for Toxic Substances and Disease Registry. ToxFAQs for Arsenic; 2007 [cited 2014 Feb 16]. Available from: http://www.atsdr.cdc.gov/toxfaqs/tf.asp?id=19&tid=3.
29. Alwis KU, Blount BC, Britt AS, Patel D, Ashley DL. Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal Chim Acta 2012;750:152-60.
30. Avila-Tang E, Al-Delaimy WK, Ashley DL, Benowitz N, Bernert JT, Kim S, et al. Assessing secondhand smoke using biological markers. Tob Control 2013;22:164-71.
31. Goniewicz ML, Havel CM, Peng MW, Jacob P III, Dempsey D, Yu L, et al. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer Epidemiol Biomarkers Prev 2009;18:3421-5.
32. Stepanov I, Jensen J, Hatsukami D, Hecht SS. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res 2006;8:309-13.
33. Borgerding MF, Bodnar JA, Curtin GM, Swauger JE. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007. Regul Toxicol Pharmacol 2012;64:367-87.
34. Delnevo CD, Wackowski OA, Giovenco DP, Manderski MT, Hrywna M, Ling PM. Examiningmarket trends in the United States smokeless tobacco use: 2005-2011. Tob Control 2014;23:107-12.